Blake Borgeson - 01 Oct 2024 Form 4 Insider Report for RECURSION PHARMACEUTICALS, INC. (RXRX)

Role
Director
Signature
/s/Jonathan Golightly, attorney-in-fact
Issuer symbol
RXRX
Transactions as of
01 Oct 2024
Transactions value $
$0
Form type
4
Filing time
04 Oct 2024, 18:30:29
Previous filing
19 Sep 2024
Next filing
17 Oct 2024

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction RXRX Class A Common Stock Award $0 +2.03K +0.03% $0.00 7.1M 01 Oct 2024 Direct F1
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 The shares were issued pursuant to the Issuer's Outside Director Compensation Policy.